Qingyu Ma

2.7k total citations · 1 hit paper
78 papers, 1.9k citations indexed

About

Qingyu Ma is a scholar working on Molecular Biology, Biological Psychiatry and Behavioral Neuroscience. According to data from OpenAlex, Qingyu Ma has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 27 papers in Biological Psychiatry and 19 papers in Behavioral Neuroscience. Recurrent topics in Qingyu Ma's work include Tryptophan and brain disorders (27 papers), Stress Responses and Cortisol (19 papers) and Gut microbiota and health (16 papers). Qingyu Ma is often cited by papers focused on Tryptophan and brain disorders (27 papers), Stress Responses and Cortisol (19 papers) and Gut microbiota and health (16 papers). Qingyu Ma collaborates with scholars based in China, United States and Singapore. Qingyu Ma's co-authors include Jiaxu Chen, Xiaojuan Li, Yongliang Zhuang, Yueyun Liu, Wenzhi Hao, Juxiu Li, Huicui Liu, Liping Sun, Chenxi Nie and Zhifei Chen and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Qingyu Ma

75 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3

2024 56 citations Wenzhi Hao, Qingyu Ma et al. profile →

Peers

Qingyu Ma

PHYSI

PHARM

Mangala Lahkar India

Hossein Amini-Khoei Iran

Jian‐You Guo China

Qiong Wang China

Naheed Banu India

Shafiqur Rahman United States

Cong Lü China

Vijayasree V. Giridharan United States

Paolo Tucci Italy

Xiaoxia Gao China

Mangala Lahkar India

Qingyu Ma

792 ×0.9

527 ×0.9

322 ×1.0

305 ×1.1

PHYSI

279 ×1.6

PHARM

Citations per year, relative to Qingyu Ma Qingyu Ma (= 1×) peers Mangala Lahkar

Countries citing papers authored by Qingyu Ma

Since Specialization

Citations

This map shows the geographic impact of Qingyu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Ma more than expected).

Fields of papers citing papers by Qingyu Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Ma. The network helps show where Qingyu Ma may publish in the future.

Co-authorship network of co-authors of Qingyu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Ma. A scholar is included among the top collaborators of Qingyu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Ma. Qingyu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dai, Hui, et al.. (2024). A new late-diverging non-hadrosaurid hadrosauroid (Dinosauria: Ornithopoda) from southwest China: Support for interchange of dinosaur faunas across East Asia during the Late Cretaceous. Cretaceous Research. 166. 105995–105995.

Wang, Xihong, Qingyu Ma, Xuan Zhou, et al.. (2024). Xiaoyao Pills, a Chinese patent medicine, treats mild and moderate depression: A randomized clinical trial combined with DNA methylation analysis. Phytomedicine. 130. 155660–155660. 8 indexed citations

Yuan, Naijun, Wenjun Zhu, Qingyu Ma, et al.. (2024). Luteolin ameliorates chronic stress-induced depressive-like behaviors in mice by promoting the Arginase-1+ microglial phenotype via a PPARγ-dependent mechanism. Acta Pharmacologica Sinica. 46(3). 575–591. 9 indexed citations

Qiu, Wenhui, et al.. (2024). Improving precision management of anxiety disorders: a Mendelian randomization study targeting specific gut microbiota and associated metabolites. Frontiers in Microbiology. 15. 1380912–1380912. 4 indexed citations

Qiu, Wenqi, Qian Wu, Kaiwen Zhang, et al.. (2023). Xiaoyaosan ameliorates depressive-like behavior and susceptibility to glucose intolerance in rat: involvement of LepR-STAT3/PI3K pathway in hypothalamic arcuate nucleus. BMC Complementary Medicine and Therapies. 23(1). 116–116. 8 indexed citations

Zhou, Xuan, Qingyu Ma, Jia-Jia Qin, et al.. (2023). Efficacy and safety of Chinese patent medicine Xiao Yao San in polycystic ovary syndrome: A systematic review and meta-analysis. Journal of Ethnopharmacology. 313. 116517–116517. 5 indexed citations

Zhu, Wenjun, Naijun Yuan, Minyi Huang, et al.. (2023). Mapping the scientific research on bipolar disorder: A scientometric study of hotspots, bursts, and trends. Journal of Affective Disorders. 340. 626–638. 2 indexed citations

Guo, Yu, Qingyu Ma, Xuan Zhou, et al.. (2022). A Systematic Review and Meta-Analysis Protocol on How Best to Use Non-Pharmacologic Therapies to Manage Chronic Low Back Pain and Associated Depression. Journal of Pain Research. Volume 15. 3509–3521.

Nie, Chenxi, Xiaoqing Xie, Huicui Liu, et al.. (2022). Galactooligosaccharides ameliorate dietary advanced glycation end product-induced intestinal barrier damage in C57BL/6 mice by modulation of the intestinal microbiome. Food & Function. 14(2). 845–856. 6 indexed citations

10.

Chen, Jianbei, Xiaojuan Li, Qian Wu, et al.. (2022). Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression. Frontiers in Pharmacology. 13. 925514–925514. 36 indexed citations

11.

Liu, Chenyue, Jianbei Chen, Yueyun Liu, et al.. (2022). Saikosaponin D exerts antidepressant effect by regulating Homer1-mGluR5 and mTOR signaling in a rat model of chronic unpredictable mild stress. Chinese Medicine. 17(1). 60–60. 24 indexed citations

12.

Liu, Chenyue, Yueyun Liu, Qingyu Ma, et al.. (2021). Xiaoyaosan Alleviates Hippocampal Glutamate-Induced Toxicity in the CUMS Rats via NR2B and PI3K/Akt Signaling Pathway. Frontiers in Pharmacology. 12. 586788–586788. 56 indexed citations

13.

Zhu, Huizheng, et al.. (2021). Xiaoyaosan Exerts Therapeutic Effects on the Colon of Chronic Restraint Stress Model Rats via the Regulation of Immunoinflammatory Activation Induced by the TLR4/NLRP3 Inflammasome Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–18. 15 indexed citations

14.

Chen, Jianbei, et al.. (2021). Bioinformatics analysis of a TF-miRNA-lncRNA regulatory network in major depressive disorder. Psychiatry Research. 299. 113842–113842. 8 indexed citations

15.

Yan, Zhiyi, Haiyan Jiao, Jianbei Chen, et al.. (2021). Antidepressant Mechanism of Traditional Chinese Medicine Formula Xiaoyaosan in CUMS-Induced Depressed Mouse Model via RIPK1-RIPK3-MLKL Mediated Necroptosis Based on Network Pharmacology Analysis. Frontiers in Pharmacology. 12. 773562–773562. 31 indexed citations

16.

Yuan, Naijun, Kairui Tang, Hua Gan, et al.. (2021). Integrating Clinical and Genomic Analyses of Hippocampal-Prefrontal Circuit Disorder in Depression. Frontiers in Genetics. 11. 565749–565749. 5 indexed citations

17.

Yang, Juan, Jeffrey S. Brault, Qingyu Ma, et al.. (2020). Tui Na for Chronic Nonspecific Low Back Pain: Protocol for a Systematic Review and Meta-analysis. JMIR Research Protocols. 10(1). e20615–e20615. 2 indexed citations

18.

Liu, Juan, et al.. (2020). Coptis inhibited epithelial–mesenchymal transition and fibrogenesis of diabetic nephropathy through lncRNA CLYBL-AS2-miR-204-5p-SNAI1 axis. Journal of drug targeting. 28(9). 939–948. 6 indexed citations

19.

Ding, Xiufang, Yan Liu, Zhiyi Yan, et al.. (2017). Involvement of Normalized Glial Fibrillary Acidic Protein Expression in the Hippocampi in Antidepressant‐Like Effects of Xiaoyaosan on Chronically Stressed Mice. Evidence-based Complementary and Alternative Medicine. 2017(1). 1960584–1960584. 25 indexed citations

20.

Ma, Qingyu, et al.. (2009). Research Situation and Prospect of Ci-xue Therapy and its Mechanism. Traditional Chinese Medicine. 31(2). 179–181. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact